💊Kyowa Hakko Kirin News、Ultragenyx and Kyowa Hakko Kirin Announce FDA Acceptance and Priority Review Designation of Burosumab’s Biologics License Application 20171010 Wednesday October 11th, 2017By Tokio X'press FDA, JPN kyowa-kirin
💊Notice Regarding Implementation of New Drug Discovery Program “JOINUS” Using Drug Repositioning Compound Libraries by Astellas Pharma, Mitsubishi Tanabe Pharma and Daiichi Sankyo Wednesday October 11th, 2017By Tokio X'press JPN, Pharmaceutical Astellas
🔬Elucidation of genome mutation in iPS cells | RIKEN Wednesday October 11th, 2017By Tokio X'press IPS, Riken, JPN Riken
🎗Basic agreement on marine LNG fuel supply with Mitsubishi Corporation, Gas 4 Sea, Statoil Wednesday October 11th, 2017By Tokio X'press LNG, JPN mitsubishicorp
⛽Spot LNG price survey ⛽Spot LNG price survey Wednesday October 11th, 2017By Tokio X'press LNG, JPN METI
